Integrated BA and HIV RR Counseling for MSM With Stimulant Abuse
Study Details
Study Description
Brief Summary
This study seeks primarily to test, in a two-arm randomized controlled trial (RCT), the efficacy of Project IMPACT, an intervention that integrates Behavioral Activation (BA) with HIV risk reduction (RR) counseling for HIV-uninfected men who have sex with men (MSM) with stimulant use disorder at risk for HIV via sexual behavior. HIV-uninfected MSM with a diagnosis of stimulant use disorder will be equally randomized to one of two study arms: (1) the Project IMPACT intervention, BA-RR counseling, which lasts ten sessions; and (2) the standard of care (SOC) comparison condition, including two equivalent sexual risk-reduction counseling sessions. Participants will be followed for one year post-randomization, with assessments at months four, eight, and 12.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Project IMPACT targets both stimulant use and sexual risk reduction in effort to help individuals relearn how to enjoy safe but pleasurable activities. The intervention integrates BA, an evidence-based cognitive behavior therapy for improving mood and increasing activity, incorporated with RR counseling aimed to reduce risky sexual practices, and potential HIV acquisition. This RCT is a two-arm efficacy trial, comparing the Project IMPACT Intervention with a SOC arm. All participants will receive HIV testing, pre-/post-test risk reduction counseling, oral swab toxicology test at baseline and 12 months, assessment of interest/indication for Pre-Exposure Prophylaxis (PrEP) per Center for Disease Control guidelines, and active referral to local PrEP services as standard-of-care. Finally, the RCT will integrate resource utilization and cost-effectiveness analyses to examine cost efficiency of the Project IMPACT Intervention as a component of data analysis.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Standard of Care (SOC) Sexual risk-reduction counseling sessions. |
Behavioral: Standard of Care
Two counseling sessions
|
Experimental: Behavioral Activation & Risk Reduction Counseling Behavioral activation with risk reduction counseling. |
Behavioral: IMPACT
Ten counseling sessions
|
Outcome Measures
Primary Outcome Measures
- Reduction in Condomless Anal Sex Acts (CAS) over study follow-up [Baseline, 4 month, 8 month, 12 month]
A self reported change in the number of CAS with men without protection of PrEP
Secondary Outcome Measures
- Reduction in the number of stimulant use episodes over study follow-up [Baseline, 4 month, 8 month, 12 month]
A self reported change in the number of stimulant use episodes over study follow-up
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 18 or older
-
Assigned male at birth
-
HIV-uninfected verified via rapid HIV test
-
Self-reports in the past four months: CAS receptive or insertive with a cisgender male sexual partner, while using stimulants and without the protection of Pre-Exposure Prophylaxis (PrEP)*
-
Able to read, speak, and understand English
-
Willing and able to provide informed consent
Exclusion Criteria:
-
Does not live in the greater Boston or Miami areas, or will move away from Boston or Miami within the next 12 months
-
Self-reports being 100% adherent to PrEP in the last four months
-
Unable to provide informed consent due to severe mental or physical illness, or substance intoxication at the time of interview
-
Discovery of active suicidal ideation at the time of interview (participants will be referred immediately for treatment, but may join the study once resolved)-
-
Involvement in any other HIV Prevention study that may interfere with the ability to test major study outcomes (e.g. another sexual risk reduction intervention or PrEP adherence intervention)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Miami | Miami | Florida | United States | 331462926 |
2 | Fenway Community Health Center | Boston | Massachusetts | United States | 022154302 |
Sponsors and Collaborators
- University of California, Los Angeles
- University of Miami
- The Fenway Institute
- Brown University
Investigators
- Principal Investigator: Matthew J Mimiaga, ScD, MPH, University of California, Los Angeles, Fielding School of Public Health
- Principal Investigator: Steve Safren, PhD, University of Miami
Study Documents (Full-Text)
More Information
Publications
None provided.- 1R01DA042805-01A1